A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity

Nioi, Paul, Nguyen, Truyen·2007·Biochemical and Biophysical Research Communications

Cited by (212)

Items 101–200 of 212

  1. AberrantKeap1methylation in breast cancer and association with clinicopathological features
    Raffaela Barbano, Lucia Anna Muscarella, Barbara Pasculli, Vanna Maria Valori, Andrea Fontana, Michelina Coco, Annamaria la Torre, Teresa Balsamo, Maria Luana Poeta, Giovanni Francesco Marangi et al. · 2012 · Epigenetics
  2. The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer
    Annette L. Hayden, James Douglas, Matthew Sommerlad, Lawrence Peter Andrews, Katherine Gould, Syed A. Hussain, Gareth J. Thomas, Graham Packham, Simon J. Crabb · 2014 · Urologic Oncology Seminars and Original Investigations
  3. Targeting cancer-cell mitochondria and metabolism to improve radiotherapy response
    Emma McCann, Jacintha N O'Sullivan, Simone Marcone · 2020 · Translational Oncology
  4. Topics on Drug Metabolism
    James William Paxton · 2012 · InTech eBooks
  5. Transcription factor Nrf2 maintains the basal expression of Mdm2: An implication of the regulation of p53 signaling by Nrf2
    Aram You, Chang-Won Nam, Nobunao Wakabayashi, Masayuki P. Yamamoto, Thomas W. Kensler, Mi-Kyoung Kwak · 2011 · Archives of Biochemistry and Biophysics
  6. Glucose-6-phosphate dehydrogenase and transketolase modulate breast cancer cell metabolic reprogramming and correlate with poor patient outcome
    Adrián Benito, Ibrahim H. Polat, Verónique Noé, Carlos J. Ciudad, Silvia Marín, Marta Cascante · 2017 · Oncotarget
  7. Xenobiotic-Activated Receptors: From Transcription to Drug Metabolism to Disease
    Qiang Ma · 2008 · Chemical Research in Toxicology
  8. Clinical Implications of KEAP1-NFE2L2 Mutations in NSCLC
    Jessica A. Hellyer, Sukhmani Kaur Padda, Maximilian Diehn, Heather A. Wakelee · 2020 · Journal of Thoracic Oncology
  9. Post‐transcriptional regulation of Nrf2‐mRNA by the mRNA‐binding proteins HuR and AUF1
    Jesse R. Poganik, Marcus J. C. Long, Michael T. Disare, Xuyu Liu, Sung‐Hee Chang, Timothy Hla, Yimon Aye · 2019 · The FASEB Journal
  10. Correlation of Nrf2, HO-1, and MRP3 in Gallbladder Cancer and Their Relationships to Clinicopathologic Features and Survival
    Jiansheng Wang, Mingxin Zhang, Lingmin Zhang, Hui Cai, Suna Zhou, Jia Zhang, Yang Wang · 2010 · Journal of Surgical Research
  11. Role of Nrf2 Signaling Cascade in Breast Cancer: Strategies and Treatment
    Hitesh Kumar, Rachna M. Kumar, Devanjali Bhattacharjee, Preethi Somanna, Vikas Kumar Jain · 2022 · Frontiers in Pharmacology
  12. Trigonelline inhibits Nrf2 via EGFR signalling pathway and augments efficacy of Cisplatin and Etoposide in NSCLC cells
    Chandrani Fouzder, Alpana Mukhuty, Sandip Mukherjee, Chandan Malick, Rakesh Kundu · 2020 · Toxicology in Vitro
  13. KEAP1-Dependent Synthetic Lethality Induced by AKT and TXNRD1 Inhibitors in Lung Cancer
    Bingbing Dai, Suk‐Young Yoo, Geoffrey A. Bartholomeusz, Ryan A. Graham, Mourad Majidi, Shaoyu Yan, Jieru Meng, Lin Ji, Kevin R. Coombes, John Dorrance Minna et al. · 2013 · Cancer Research
  14. Regulation of cell signaling pathways by dietary agents for cancer prevention and treatment
    Manoj Kumar Pandey, Subash C. Gupta, Ali Nabavizadeh, Bharat Bhushan Aggarwal · 2017 · Seminars in Cancer Biology
  15. xCT inhibition sensitizes tumors to γ-radiation via glutathione reduction
    Lara Cobler, Hui Zhang, Poojan Suri, Catherine Park, Luika Timmerman · 2018 · Oncotarget
  16. Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene
    Lisa Becks, Misty Prince, Hannah C. Burson, Christopher Christophe, Mason Broadway, Ken Itoh, Masayuki P. Yamamoto, James Michael Mathis, Elysse A. Orchard, Runhua Shi et al. · 2010 · BMC Cancer
  17. Nrf2: bane or blessing in cancer?
    Mingjun Xiang, Akhileshwar Namani, ShiJun Wu, XiaoLi Wang · 2014 · Journal of Cancer Research and Clinical Oncology
  18. The Role of Nrf2 in Migration and Invasion of Human Glioma Cell U251
    Hao Pan, Handong Wang, Lin Zhu, Lei Mao, Liang Qiao, Xingfen Su · 2011 · World Neurosurgery
  19. The see-saw of Keap1-Nrf2 pathway in cancer
    Poorti Pandey, Alok Kumar Singh, Mritunjai Singh, Mallika Tewari, Hari Shankar Shukla, Indrajeet Singh Gambhir · 2017 · Critical Reviews in Oncology/Hematology
  20. Functional Aspects of Redox Control During Neuroinflammation
    Sergio Rosales‐Corral, Russel Joseph Reiter, Dun‐Xian Tan, Genaro G. Ortiz, Gabriela del Carmen López-Armas · 2009 · Antioxidants and Redox Signaling
  21. Non-enzymatic post-translational protein modifications and proteostasis network deregulation in carcinogenesis
    Ioannis P. Trougakos, Fabiola Sesti, Eleni N. Tsakiri, Vassilis G. Gorgoulis · 2013 · Journal of Proteomics
  22. Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs
    Federico Pio Fabrizio, Angelo Sparaneo, Domenico Trombetta, Lucia Anna Muscarella · 2018 · Oxidative Medicine and Cellular Longevity
  23. Role of Reductive versus Oxidative Stress in Tumor Progression and Anticancer Drug Resistance
    Kyung‐Soo Chun, Do‐Hee Kim, Young‐Joon Surh · 2021 · Cells
  24. A possible gene silencing mechanism: Hypermethylation of the Keap1 promoter abrogates binding of the transcription factor Sp1 in lung cancer cells
    Duo Guo, Bo Wu, Jihong Yan, Xiaoshuang Li, Haimei Sun, Deshan Zhou · 2012 · Biochemical and Biophysical Research Communications
  25. Nrf2 Signaling in Renal Cell Carcinoma: A Potential Candidate for the Development of Novel Therapeutic Strategies
    Valentina Schiavoni, Monica Emanuelli, Giulio Milanese, Andrea Benedetto Galosi, Veronica Pompei, Eleonora Salvolini, Roberto Campagna · 2024 · International Journal of Molecular Sciences
  26. Effects of diclofenac on the expression of Nrf2 and its downstream target genes in mosquito fish (Gambusia affinis)
    Shuang Bao, Xiangping Nie, Ruikang Ou, Chao Wang, Peijia Ku, Kaibin Li · 2017 · Aquatic Toxicology
  27. Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells
    Emiliano Panieri, Luciano Saso · 2021 · Antioxidants and Redox Signaling
  28. Nrf2 transcriptional derepression from Keap1 by dietary polyphenols
    Henry K. Bayele, Edward S. Debnam, Surjit Kaila Srai · 2015 · Biochemical and Biophysical Research Communications
  29. NRF2 inhibition represses ErbB2 signaling in ovarian carcinoma cells: Implications for tumor growth retardation and docetaxel sensitivity
    Manandhar, Sarala, Choi, Bo-hyun, Jung, Kyeong-Ah, Ryoo, In-geun, Song, Mingu, Kang, Su Jin, Choi, Han-Gon, Kim, Jung-Ae, Park, Pil-Hoon, Kwak, Mi-Kyoung · 2012 · Free Radical Biology and Medicine
  30. Significance of NRF2 in physiological and pathological conditions an comprehensive review
    Michalina Kryszczuk, Oksana Kowalczuk · 2022 · Archives of Biochemistry and Biophysics
  31. Knockdown of NF-E2-related factor 2 inhibits the proliferation and growth of U251MG human glioma cells in a mouse xenograft model
    Xiangjun Ji, SUI-HUA CHEN, Lin Zhu, Hao Pan, Yuan Zhou, Wei Li, Wanchun You, Chao-Chao Gao, Jianhong Zhu, Kuan Jiang et al. · 2013 · Oncology Reports
  32. Implications of aging and the endoplasmic reticulum unfolded protein response on the molecular modality of breast cancer
    Rinki Minakshi, Safikur Rahman, Arif Tasleem Jan, Archana Ayyagari, Jihoe Kim · 2017 · Experimental & Molecular Medicine
  33. Anticancer Drug Metabolism: Chemotherapy Resistance and New Therapeutic Approaches
    Hanane Akhdar, Claire Legendre, Caroline Aninat, Fabrice More · 2012 · InTech eBooks
  34. Multifaceted Roles of the KEAP1–NRF2 System in Cancer and Inflammatory Disease Milieu
    Harit Panda, Huaichun Wen, Mikiko Suzuki, Masayuki P. Yamamoto · 2022 · Antioxidants
  35. The ‘N-factors’ in pancreatic cancer: functional relevance of NF-κB, NFAT and Nrf2 in pancreatic cancer
    Alexander Arlt, H. Schäfer, Holger Kalthoff · 2012 · Oncogenesis
  36. Frequent Tumor Burden Monitoring of Esophageal Squamous Cell Carcinoma With Circulating Tumor DNA Using Individually Designed Digital Polymerase Chain Reaction
    Takeshi Iwaya, Fumitaka Endo, Mizunori Yaegashi, Noriyuki Sasaki, Ryosuke Fujisawa, H. Hiraki, Y. Akiyama, A. Sasaki, Y. Suzuki, M. Masuda et al. · 2020 · Gastroenterology
  37. Hypermethylation of the Keap1 gene inactivates its function, promotes Nrf2 nuclear accumulation, and is involved in arsenite-induced human keratinocyte transformation
    Dapeng Wang, Yuan Ma, Xu Yang, Xiguo Xu, Yingying Zhao, Zhen Hua Zhu, Xiaojuan Wang, Hanyi Deng, Chunchun Li, Fenfang Gao et al. · 2015 · Free Radical Biology and Medicine
  38. Resistance of neuroblastoma GI-ME-N cell line to glutathione depletion involves Nrf2 and heme oxygenase-1
    Anna Lisa Furfaro, José Raúl Zumba Macay, Barbara Marengo, Mariapaola Nitti, Alessia Parodi, Daniela Fenoglio, Umberto Maria Marinari, Maria Adelaide Pronzato, Cinzia Domenicotti, Nicola Traverso · 2011 · Free Radical Biology and Medicine
  39. Dual role of heme iron in cancer; promotor of carcinogenesis and an inducer of tumour suppression
    Sujani Madhurika Kodagoda Gamage, Katherine Ting‐Wei Lee, Lakal Dissabandara, Alfred King-yin Lam, Vinod Gopalan · 2021 · Experimental and Molecular Pathology
  40. Oncogenic transformation of mesenchymal stem cells decreases Nrf2 expression favoring in vivo tumor growth and poorer survival
    Juan Manuel Funes, Stephen R Henderson, Rachel Kaufman, James M. Flanagan, Mathew P. Robson, Barbara R. Pedley, Salvador Moncada, Chris Boshoff · 2014 · Molecular Cancer
  41. Promoter demethylation of nuclear factor-erythroid 2-related factor 2 gene in drug-resistant colon cancer cells
    Xiaoqian Zhao, Yifei Zhang, YI-FANG XIA, Zhongmei Zhou, Ying-Qing Cao · 2015 · Oncology Letters
  42. RETRACTED ARTICLE: Downregulation of RKIP promotes radioresistance of nasopharyngeal carcinoma by activating NRF2/NQO1 axis via downregulating miR-450b-5p
    Wei Huang, Guang-Qing Shi, Zhong Yong, Jian Li, Juan Qiu, Yan Wei Cao, Yongfeng Zhao, Yuan Li · 2020 · Cell Death and Disease · Retracted
  43. β-Sitosterol targets ASS1 for Nrf2 ubiquitin-dependent degradation, inducing ROS-mediated apoptosis via the PTEN/PI3K/AKT signaling pathway in ovarian cancer
    Haoyu Wang, Jingchun Liu, Zihui Zhang, Jiaxin Peng, Zhi Wang, Lian Yang, Xinqi Wang, Siyuan Hu, Hong Li · 2024 · Free Radical Biology and Medicine
  44. Effects of different extracts of curcumin on TPC1 papillary thyroid cancer cell line
    Angelica Perna, Antonio De Luca, Laura Adelfi, Tammaro Pasquale, Bruno Varriale, Teresa Esposito · 2018 · BMC Complementary and Alternative Medicine
  45. The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and β-TrCP-NRF2 interactions in cancer chemoresistance
    Rohini Srivastava, Raquel Fernández-Ginés, José Antonio Encinar, Antonio Cuadrado, Geoffrey Wells · 2022 · Free Radical Biology and Medicine
  46. ERK and PI3K signaling cascades induce Nrf2 activation and regulate cell viability partly through Nrf2 in human glioblastoma cells
    Zixiang Cong, Handong Wang, Jiawei Wang, Yuan Zhou, Hao Pan, Ding-Ding Zhang, Lin Zhu · 2013 · Oncology Reports
  47. Genetic inactivation of Nrf2 prevents clonal expansion of initiated cells in a nutritional model of rat hepatocarcinogenesis
    Claudia Orrù, Marta Szydlowska, Keiko Taguchi, Patrizia Zavattari, Andrea Perra, Masayuki P. Yamamoto, Amedeo Columbano · 2018 · Journal of Hepatology
  48. Dithiolethiones: A Privileged Pharmacophore for Anticancer Therapy and Chemoprevention
    Mohd. Imran Ansari, Mohd M. Khan, Mohammad Saquib, Shahnaaz Khatoon, Mohd Kamil Hussain · 2018 · Future Medicinal Chemistry
  49. The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer
    Hadi Fakheri, Mir Amirhossein Sajadi, Ahmad Afrashteh, Wenbiao Ma, Lei Xia, Mohammad Valilo · 2023 · Biochemia Medica
  50. Rexinoid inhibits Nrf2-mediated transcription through retinoid X receptor alpha
    Jiaguo Wu, Hongyan Wang, Xiuwen Tang · 2014 · Biochemical and Biophysical Research Communications
  51. Unique Pattern of Component Gene Disruption in the NRF2 Inhibitor KEAP1/CUL3/RBX1 E3-Ubiquitin Ligase Complex in Serous Ovarian Cancer
    Victor D. Martínez, Emily A. Vucic, Kelsie L. Thu, Larissa A. Pikor, Roland Hubaux, Wan L. Lam · 2014 · BioMed Research International
  52. Potential Protective and Therapeutic Roles of the Nrf2 Pathway in Ocular Diseases: An Update
    Ming-xuan Wang, Jing Zhao, Hong Zhang, Ke Li, Lingzhi Niu, Yuanping Wang, Yajuan Zheng · 2020 · Oxidative Medicine and Cellular Longevity
  53. Importance of the Keap1-Nrf2 pathway in NSCLC: Is it a possible biomarker? (Review)
    Raúl Barrera Rodríguez · 2018 · Biomedical Reports
  54. Soft Cysteine Signaling Network: The Functional Significance of Cysteine in Protein Function and the Soft Acids/Bases Thiol Chemistry That Facilitates Cysteine Modification
    Ryan S. Wible, Thomas R. Sutter · 2017 · Chemical Research in Toxicology
  55. Cancer chemoprevention via activation of proteostatic modules
    Aimilia D. Sklirou, Eleni‐Dimitra Papanagnou, Nikolas Fokialakis, Ioannis P. Trougakos · 2017 · Cancer Letters
  56. Nrf2 expression in endometrial serous carcinomas and its precancers.
    Ning Chen, Xiaofang Yi, Nisreen Abushahin, Shujie Pang, Donna Zhang, Beihua Kong, Wenxin Zheng · 2010 · PubMed Central
  57. 2-Deoxy-D-glucose and 6-aminonicotinamide-mediated Nrf2 down regulation leads to radiosensitization of malignant cells via abrogation of GSH-mediated defense
    Pradeep Sharma, Rajeev Kumar Varshney · 2012 · Free Radical Research
  58. Methylation Density Pattern of KEAP1 Gene in Lung Cancer Cell Lines Detected by Quantitative Methylation Specific PCR and Pyrosequencing
    Federico Pio Fabrizio, Angelo Sparaneo, Flavia Centra, Domenico Trombetta, Clelia Tiziana Storlazzi, Paolo Graziano, Evaristo Maiello, Vito Michele Fazio, Lucia Anna Muscarella · 2019 · International Journal of Molecular Sciences
  59. Correlation of Nrf2 and HIF-1α in glioblastoma and their relationships to clinicopathologic features and survival
    Xiangjun Ji, Handong Wang, Jianhong Zhu, Yong Tang, Yuan Zhou, Lin Zhu, Chao-Chao Gao, Wei Li, Wanchun You, Bo Yu et al. · 2013 · Neurological Research
  60. Mitochondrial bioenergetics and drug-induced toxicity in a panel of mouse embryonic fibroblasts with mitochondrial DNA single nucleotide polymorphisms
    Cláudia V. Pereira, Paulo Jorge Oliveira, Yvonne Will, Sashi Nadanaciva · 2012 · Toxicology and Applied Pharmacology
  61. Nrf2 expression is associated with poor outcome in osteosarcoma
    Jae Young Park, Youn Wha Kim, Yong-Koo Park · 2012 · Pathology
  62. Regulation of Cell Proliferation and Nrf2-Mediated Antioxidant Defense: Conservation of Keap1 Cysteines and Nrf2 Binding Site in the Context of the Evolution of KLHL Family
    Gregory A. Shilovsky, Daria V. Dibrova · 2023 · Life
  63. NRF2 level is negatively correlated with TGF-β1-induced lung cancer motility and migration via NOX4-ROS signaling
    Da-Young Ryu, Jinhee Lee, Mi‐Kyoung Kwak · 2020 · Archives of Pharmacal Research
  64. NRF2: Master regulator of cellular homeostasis and therapeutic vulnerability in cancer
    Wei-Tai Chen, Nicholas W. McKee, Damaris Kuhnell, Matthew B. Dodson · 2026 · Redox Biology
  65. Mechanisms Underlying Chemopreventive Effects of Flavonoids via Multiple Signaling Nodes within Nrf2-ARE and AhR-XRE Gene Regulatory Networks
    Han Xiao, Feng-Lin Lu, Derek Stewart, Yiguo Zhang · 2013 · Current Chemical Biology
  66. Cullin-3 protein expression levels correlate with breast cancer progression
    Kelly K. Haagenson, Larry R. Tait, Juan Wang, Malathy P.V. Shekhar, Lisa Polin, Wei Chen, Gen Sheng Wu · 2012 · Cancer Biology & Therapy
  67. Is redox signaling a feasible target for overcoming multidrug resistance in cancer chemotherapy?
    Manuela Polimeni, Elena Gazzano · 2014 · Frontiers in Pharmacology
  68. Effect of stable inhibition of NRF2 on doxorubicin sensitivity in human ovarian carcinoma OV90 cells
    Sarala Manandhar, Sangwhan Lee, Mi‐Kyoung Kwak · 2010 · Archives of Pharmacal Research
  69. Oncogenic mutations in KEAP1 disturbing inhibitory Nrf2‐Keap1 interaction: Activation of antioxidative pathway in papillary thyroid carcinoma
    Debora Lúcia Seguro Danilovic, Evandro Sobroza de Mello, Eliana Frazzatto, Alda Wakamatsu, Alexander A.L. Jorge, Ana O. Hoff, Suemi Marui · 2018 · Head & Neck
  70. Evaluation of the Epigenetic Demethylation of NRF2, a Master Transcription Factor for Antioxidant Enzymes, in Colorectal Cancer
    Zahra Taheri, Hamid Asadzadeh Aghdaei, Shiva Irani, Mohammad Hossein Modarressi, Zahra Noormohammadi · 2020 · Reports of Biochemistry and Molecular Biology
  71. AURKA emerges as a vulnerable target for KEAP1-deficient non-small cell lung cancer by activation of asparagine synthesis
    Bing Deng, Fang Liu, Nana Chen, Xinhao Li, Jie Lei, Ning Chen, Jingjing Wu, Xuan Wang, Jie Lu, Mouxiang Fang et al. · 2024 · Cell Death and Disease
  72. Association of single-nucleotide polymorphisms of the KEAP1 gene with the risk of various human diseases and its functional impact using in silico analysis
    Dhamodharan Umapathy, Ponjayanthi Balashanmugam, Dornadula Sireesh, Elango Bhakkiyalakshmi, Kunka Mohanram Ramkumar · 2018 · Pharmacological Research
  73. The Potential Role of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) in Glaucoma: A Review
    Mingxuan Wang, Jia Li, Yajuan Zheng · 2020 · Medical Science Monitor
  74. Base excision repair accessory factors in senescence avoidance and resistance to treatments
    Elise Vickridge, Camila Cristina Fraga Faraco, Alain Nepveu · 2022 · Cancer Drug Resistance
  75. Unique and overlapping roles of NRF2 and NRF1 in transcriptional regulation
    Hiroki Sekine, Hozumi Motohashi · 2023 · Journal of Clinical Biochemistry and Nutrition
  76. Expression of Keap1 and Nrf2 in diffuse large B‑cell lymphoma and its clinical significance
    Xuemei Yi, Yajun Zhao, Xue Li, Jing Zhang, Yujie Qiao, Qianqian Jin, Hongling Li · 2018 · Experimental and Therapeutic Medicine
  77. Redox and metabolic reprogramming in breast cancer and cancer‐associated adipose tissue
    Tamara Zakić, Vanja Pekovic‐Vaughan, Aleksandra Čvoro, Aleksandra Korać, Aleksandra Janković, Bato Korać · 2023 · FEBS Letters
  78. An organoid library of human esophageal squamous cell carcinomas (ESCCs) uncovers the chemotherapy-resistant ESCC features
    Shunsaku Nakagawa, Taku Sato, Eriko Ohashi, Mihoko Kajita, Fuyuki Miya, Kouhei Yamamoto, Hiroki Yotsumata, Kazuya Yamaguchi, Yasuaki Nakajima, Akinori Miura et al. · 2025 · Communications Biology
  79. Increased BTB-Kelch type substrate adaptor protein immunoreactivity associates with advanced stage and poor differentiation in renal cell carcinoma
    Markku H. Vaarala · 2009 · Oncology Reports
  80. Expression of Antioxidant Enzymes in Patients with Uterine Polyp, Myoma, Hyperplasia, and Adenocarcinoma
    Ana Todorović, Snežana Pejić, Ljubica Gavrilović, Ivan Pavlović, Vesna Stojiljković, Nataša Popović, Snežana B. Pajović · 2019 · Antioxidants
  81. CACUL1/CAC1 Regulates the Antioxidant Response by Stabilizing Nrf2
    Yu Kigoshi, Tomomi Fukuda, Tomoyuki Endo, Nami Hayasaka, Shun‐ichiro Iemura, Tohru Natsume, Fuminori Tsuruta, Tomoki Chiba · 2015 · Scientific Reports
  82. The identification and characterization of non-reactive inhibitor of Keap1-Nrf2 interaction through HTS using a fluorescence polarization assay
    Lili Wang, Timothy A. Lewis, Yanling Zhang, Carol Khodier, Sadagopan Magesh, Lin Chen, Daigo Inoyama, Yu Chen, Jing Zhen, Longqin Hu et al. · 2013 · Europe PMC (PubMed Central)
  83. Expression of Nuclear Factor Erythroid 2 Protein in Malignant Cutaneous Tumors
    Chang Yong Choi, Jin Young Kim, Seo Yeong Wee, Jang Hyun Lee, Doo Hyun Nam, Chul Han Kim, Moon Kyun Cho, Yoon Jin Lee, Hae Seon Nam, Sang-Han Lee et al. · 2014 · Archives of Plastic Surgery
  84. Molecular effects of cancer-associated somatic mutations on the structural and target recognition properties of Keap1
    Halema Khan, Ryan C. Killoran, Anne M. Brickenden, Jing‐Song Fan, Daiwen Yang, Wing‐Yiu Choy · 2015 · Biochemical Journal
  85. Possible involvement of granulocyte oxidative burst in Nrf2 signaling in cancer.
    Morana Jaganjac · 2010 · PubMed
  86. Nrf2-Mediated Antioxidant Response and Drug Efflux Transporters Upregulation as Possible Mechanisms of Resistance in Photodynamic Therapy of Cancers
    Olawale Razaq Ajuwon, Fleury Augustin Nsole Biteghe, Jean De La Croix Ndong, Lester M. Davids, Basiru Olaitan Ajiboye, Bartholomew I. C. Brai, Fisayo Abraham Bamisaye, John Adeolu Falode, Ikenna Maximillian Odoh, Kabirat Adegbite et al. · 2024 · OncoTargets and Therapy
  87. Neurodegeneration from Drugs and Aging‐Derived Free Radicals
    Annmarie Ramkissoon, Aaron M. Shapiro, Margaret M. Loniewska, Peter G. Wells · 2013 · Wiley eBooks
  88. Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC
    Sandra Mattu, Patrizia Zavattari, Marta Anna Kowalik, Marina Serra, Pia Sulas, Rajesh Ramavadh Pal, Elisabetta Puliga, Salvatore Sutti, Beatrice Foglia, Maurizio Parola et al. · 2021 · Cellular and Molecular Gastroenterology and Hepatology
  89. Detoxication of Chemical Carcinogens and Chemoprevention
    Melinda S. Yates, Thomas W. Kensler · 2010 · Humana Press eBooks
  90. New insights into reductive stress responses and its clinical relation in cancer
    Suman Kumar Ray, Sukhes Mukherjee · 2025 · Tissue and Cell
  91. Oxidative stress in the pathogenesis and prognosis of ovarian cancer
    Marjo Pylväs-Eerola · 2015
  92. [Relationship among areca nut, intracellular reactive oxygen species, and autophagy].
    Zhi Xu, Feng-Yuan Lü, Erhui Jiang, Xiaoping Zhao, Zheng-Jun Shang · 2020 · PubMed Central
  93. Nrf2 – Two Faces of Antioxidant System Regulation
    Michal Pastorek, Petr Müller, Bořivoj Vojtěšek · 2015 · Klinicka onkologie
  94. Hereditary Renal Cell Carcinoma
    Masaya Baba, Laura S. Schmidt, William Marston Linehan · 2017 · Springer eBooks
  95. Oxidative Stress-Dependent Cellular Toxicity and Cytoprotection during Exposure to 9, 10-phenanthraquinone, a Component of Diesel Exhaust Particles
    Keiko Taguchi · 2009 · Eisei kagaku
  96. Antioxidant of Pleurotus ostreatus (Jacq.) P. Kumn and lymphoid cancer cells
    Md. Moyen Uddin Pk, Jane O’Sullivan, Rumana Pervin, Matiar Rahman · 2021 · Elsevier eBooks
  97. Survival Strategy and Disease Pathogenesis According to the Nrf2‐Small Maf Heterodimer
    Masanobu Morita, Hozumi Motohashi · 2011
  98. Targets and promising adjuvants for improving breast tumor response to radiotherapy
    Fusen Yang, Hui Song, Weihong Wu, Junmei Guo · 2025 · Bioorganic Chemistry
  99. Keap1-Nrf2 Regulatory System and Cancer
    Keiko Taguchi, Masayuki P. Yamamoto · 2015 · Springer eBooks
  100. ACTIVATION OF ESTROGEN RECEPTOR ALPHA, ARYL HYDROCARBON RECEPTOR, AND NUCLEAR FACTOR ERYTHROID-2 LIKE 2 IN HUMAN BREAST CANCER CELLS
    Raymond Lo · 2014 · TSpace (University of Toronto)